Dec 07, 2020

Huntsman Cancer Institute Treats First Non-Small Cell Lung Cancer Patient on New Phase I Clinical Trial

The first patient in the world to be enrolled on a clinical trial of a new investigational drug, AN0025, was treated at Huntsman Cancer Institute at the University of Utah earlier this year. The drug is being studied for use in patients with non-small cell lung cancer and other solid tumors who have previously been treated with immunotherapy and whose cancers later developed ways to resist immunotherapy.

Nov 18, 2020

A Clinical Trial Helped This Lung Cancer Patient Breathe Easy

When Scott Vance went in for a COVID-19 test, he never expected it would lead to a diagnosis of stage IV lung cancer. Scott’s doctors learned a specific mutation was causing the cancer, and he began a new mutation-targeting drug approved by the FDA just two years earlier. Scott says his remarkable response to the drug has him feeling grateful clinical trials can bring these cutting-edge treatments to people like him.

Nov 13, 2020

Lung Cancer Screening Q&A

Lung cancer screening helps us find cancer early, before the cancer is able to cause symptoms. The earlier cancer is found, the easier it is to treat. Treating lung cancer at an earlier stage gives patients more treatment options. They also have a better chance of living longer. Dr. Chakravarthy Reddy answers some frequently asked questions about lung cancer screening.

Oct 30, 2020

Fighting Bench to Bedside for New Lung Cancer Treatments

Sonam Puri gets up every day to care for patients with lung cancer. Then, she carves out time to work with other researchers at Huntsman Cancer Institute to tackle why and how cancer develops in small cell and non-small cell lung cancer patients. She was attracted to apply to the 5 For The Fight Fellowship is the concept behind the organization. “People are donating $5 for somebody who has either been touched by or is battling cancer, and knowing that these single $5 donations ultimately add up to a sizeable amount just reflects how many lives are affected by cancer at large.”

Sep 29, 2020

5 For The Fight Announces Inaugural Class of Cancer Research Fellows at Huntsman Cancer Institute

5 For The Fight, a global movement inviting everyone to give $5 for the fight against cancer, today announced the inaugural recipients of the 5 For The Fight Cancer Research Fellowship in partnership with Huntsman Cancer Institute at the University of Utah.

Aug 04, 2020

Scientists Develop New Models to Accelerate Progress in Preventing Drug Resistance in Lung and Pancreas Cancers

Scientists at Huntsman Cancer Institute at the University of Utah report today the development of new models to study molecular characteristics of tumors of the lung and pancreas that are driven by mutations in a gene named NTRK1. The findings were published today in the journal Cell Reports.

Jun 02, 2020

Researchers Identify a Moving Target in Small Cell Lung Tumors

About 15 percent of lung cancers are classified as small cell lung cancer. Recent studies have indicated that four major subtypes of small cell lung cancer exist, yet approaches to tailor treatment of these subtypes have not yet become standard of care. Today in the journal Cancer Cell, scientists outline new findings about the origins of these lung cancer subtypes, paving the way for a new foundation to study this disease.

Mar 09, 2020

HCI Post-Doctoral Fellow Receives Award from the National Cancer Institute

Aria Vaishnavi, PhD, a post-doctoral fellow at Huntsman Cancer Institute at the University of Utah has received the first annual National Cancer Institute Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers. The “Early K99” grant supports researchers who need only a short period of training and mentorship after their doctoral degrees and before they’re hired into a faculty position.